Key Highlights
● More than eight in ten reporting S&P 500 companies beat estimates.
● The aggregate size of beats is about a third of the five-year average.
● It is also well below the ten-year average.
● Revenue surprises are similarly modest.
On the surface, third-quarter Earnings season looks like a triumph. According to an earnings report of November 6, more than eight in ten S&P 500 companies that have reported beat analysts' earnings estimates, comfortably above the five-year average of a little under eight in ten. About three in four topped Revenue estimates, also better than the five-year norm of roughly seven in ten.
Look closer, though, and the picture changes. The aggregate amount by which companies are beating estimates is only about a third of the five-year average, and well below the ten-year average too, reports said. Revenue surprises are similarly modest. In plain terms, companies are clearing the bar more often, but only just.
Why the gap matters
Earnings beats are partly a matter of expectations. A majority of companies typically top forecasts, so a beat is the norm rather than a surprise. What usually separates a good season from a great one is the size of the beats. Small beats suggest analysts already had a good handle on profits, leaving less room for upside shocks to drive stocks.
That fits with a season in which expectations were already high. Market data reports blended third-quarter earnings growth of nearly a third from a year earlier, a pace that left limited room for positive surprises. Another tally, from LSEG, showed roughly four in five of the 335 companies that had reported as of last Thursday beating estimates, reports said at midday Monday. The two counts used different universes and dates.
Guidance is doing the heavy lifting
With small beats, the market has keyed on outlooks. That was clear on Monday, November 9, 2026. Constellation Energy (NASDAQ:CEG) posted adjusted earnings of $5.06 a share against $3.85 expected, a rare big beat, and raised its full-year guidance; the stock soared. Monday.com (NASDAQ:MNDY), by contrast, beat on third-quarter revenue but slid after its fourth-quarter revenue outlook of $380 million to $382 million fell below consensus, according to market coverage.
Ionis Pharmaceuticals (NASDAQ:IONS) offered a starker example. Its revenue rose sharply and its operating loss was smaller than expected, but the stock plunged after it cut 2026 sales guidance for Tryngolza to about $50 million from $100 million to $110 million, according to market reports and the company's release.
After the bell, Hims & Hers Health (NYSE:HIMS) reported revenue of $890.4 million, roughly in line with estimates, but its fourth-quarter revenue guide of about $885 million fell short of the $953.1 million consensus, and the shares slipped further, reports said.
The market backdrop
The season is playing out against a volatile tape. Stocks staged a powerful rebound on Monday, with the S&P 500 up 173.08 points to 7,549.94, its best day since April 8, after the prior week's worst performance since April 2025. Market data put the index's forward price-to-earnings ratio at 17.7 as of November 5, below its five-year average of 19.8.
Guidance Over Beats
With nearly nine in ten S&P 500 companies already reported, the remaining names carry outsized weight. Nvidia's November 17 report is the biggest, and retailers such as Home Depot are among those still to come. Applied Materials and Cisco report this week. Watch both whether those companies beat and by how much, and especially what they say about the next quarter. Market data next weekly update will show whether the size of the average beat creeps back toward its historical norm or stays unusually thin.






Please wait processing your request...